High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q3
FY2026Q4
FY2027Q1
1.65B
+2.18%
0.404
-17.52%
2.86B
+2.53%
2.198
+5.17%
1.47B
+2.97%
0.509
+3.81%
Estimates Revision
The market is revising Downward the revenue expectations for Bath & Body Works, Inc. (BBWI) for FY2026, with the revenue forecasts being adjusted by -0.27% over the past three months. During the same period, the stock price has changed by -21.46%.
Revenue Estimates for FY2026
Revise Downward
-0.27%
In Past 3 Month
EPS Estimates for FY2026
Revise Downward
-0.84%
In Past 3 Month
Stock Price
Go Down
-21.46%
In Past 3 Month
12 Analyst Rating
Wall Street analysts forecast BBWI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BBWI is 34.96 USD with a low forecast of 26.00 USD and a high forecast of 40.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Buy
4 Hold
0 Sell
Moderate Buy
Current: 22.400
Low
26.00
Averages
34.96
High
40.00
Current: 22.400
Low
26.00
Averages
34.96
High
40.00
Raymond James
Olivia Tong
Outperform -> Market Perform
downgrade
2025-11-12
New
Reason
Raymond James
Olivia Tong
Price Target
2025-11-12
New
downgrade
Outperform -> Market Perform
Reason
Raymond James analyst Olivia Tong downgraded Bath & Body Works to Market Perform from Outperform without a price target. The company's growth will be below its long-term potential as improvements from better digital capabilities, product, and distribution will take time, the analyst tells investors in a research note. The firm's channel checks in the last two months suggest Bath & Body's recent innovations "have fallen short" while discounting in stores and online has increased. Raymond James cut estimates and downgraded the shares on the company's near-term challenges.
Wells Fargo
Overweight
to
NULL
downgrade
$44 -> $33
2025-10-27
Reason
Wells Fargo
Price Target
$44 -> $33
2025-10-27
downgrade
Overweight
to
NULL
Reason
Wells Fargo lowered the firm's price target on Bath & Body Works to $33 from $44 and keeps an Overweight rating on the shares. The firm is also cutting Q3 estimates, and more notably pruning 2026 EPS well below Street. Wells believes turnaround efforts are likely to be pushed out to 2026 as new CEO Heaf takes more time to reinvest in the current model.
Barclays
Equal Weight
downgrade
$32 -> $28
2025-10-20
Reason
Barclays
Price Target
$32 -> $28
2025-10-20
downgrade
Equal Weight
Reason
Barclays lowered the firm's price target on Bath & Body Works to $28 from $32 and keeps an Equal Weight rating on the shares after meeting with management. The firm believes Bath & Body's "focus on fewer" strategy and brand strength will drive a business inflection in the second half of 2026.
Morgan Stanley
Alex Straton
Overweight
downgrade
$41 -> $40
2025-09-12
Reason
Morgan Stanley
Alex Straton
Price Target
$41 -> $40
2025-09-12
downgrade
Overweight
Reason
Morgan Stanley analyst Alex Straton lowered the firm's price target on Bath & Body Works to $40 from $41 and keeps an Overweight rating on the shares after updating the firm's estimates post-Q2 results.
Barclays
Adrienne Yih
Equal Weight
maintain
$30 -> $32
2025-08-29
Reason
Barclays
Adrienne Yih
Price Target
$30 -> $32
2025-08-29
maintain
Equal Weight
Reason
Barclays analyst Adrienne Yih raised the firm's price target on Bath & Body Works to $32 from $30 and keeps an Equal Weight rating on the shares following the fiscal Q2 report. The firm says Bath & Body's tariff impacts will be largest in Q3, as inventory flows-through.
UBS
Neutral
downgrade
$36 -> $32
2025-08-29
Reason
UBS
Price Target
$36 -> $32
2025-08-29
downgrade
Neutral
Reason
UBS lowered the firm's price target on Bath & Body Works to $32 from $36 and keeps a Neutral rating on the shares following the Q2 report. The firm sees limited upside to the Street's fiscal 2025 earnings estimates. Bath & Body has few levers to drive margin upside and new CEO Daniel Heaf's wholesale channel expansion strategy could further pressure its EBIT margin expansion, the analyst tells investors in a research note.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Bath & Body Works Inc (BBWI.N) is 6.28, compared to its 5-year average forward P/E of 12.32. For a more detailed relative valuation and DCF analysis to assess Bath & Body Works Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Strongly Undervalued
5Y Average PE
12.32
Current PE
6.28
Overvalued PE
15.24
Undervalued PE
9.40
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
9.24
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
10.81
Undervalued EV/EBITDA
7.67
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
1.58
Current PS
21.96
Overvalued PS
3.86
Undervalued PS
-0.69
Financials
Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
BBWI News & Events
Events Timeline
(ET)
2025-11-04
09:03:41
Bath & Body Works Appoints Maly Bernstein as Chief Commercial Officer and Samantha Charleston as Chief Human Resources Officer
2025-09-25 (ET)
2025-09-25
19:13:37
Trump intends to implement a 50% tariff on kitchen cabinets and bathroom vanities.
2025-09-08 (ET)
2025-09-08
09:06:32
Bath & Body Works Plans to Recruit More Than 30,000 Seasonal Workers for the Holiday Season
Sign Up For More Events
Sign Up For More Events
News
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/78a741316f55de5163a560617f9f6883c0d1ce4c19fadf0b70a6c468b6580ff8.png)
Preview
4.0
11-12BenzingaBath & Body Works Analyst Changes Stance; Check Out Wednesday's Top 4 Downgrades
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/8c3fe0cf94b0a26543b82d876fec9f0bc43d5ba8dfed358ee922d83fe011121c.jpg)
Preview
8.0
11-11NASDAQ.COMSignificant Options Trading on Monday: LXU, BBWI, CXW
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/afffa0480bd12b28491f9280fcc0e48b82c2216c38077408f933207fcea1faee.png)
Preview
8.0
11-07NewsfilterBath & Body Works Announces Cash Dividend Payment
Sign Up For More News
People Also Watch
FAQ
What is Bath & Body Works Inc (BBWI) stock price today?
What is Bath & Body Works Inc (BBWI)'s business?
What is the price predicton of BBWI Stock?
What is Bath & Body Works Inc (BBWI)'s revenue for the last quarter?
What is Bath & Body Works Inc (BBWI)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Bath & Body Works Inc (BBWI)'s fundamentals?
How many employees does Bath & Body Works Inc (BBWI). have?